#METABOLOMICS WORKBENCH teklab_20180925_035957 DATATRACK_ID:1516 STUDY_ID:ST001090 ANALYSIS_ID:AN001775 PROJECT_ID:PR000729
VERSION             	1
CREATED_ON             	November 6, 2018, 11:12 am
#PROJECT
PR:PROJECT_TITLE                 	NMR metabolomics study of Gemcitabine resistant cancer cells
PR:PROJECT_TYPE                  	NMR metabolomics
PR:PROJECT_SUMMARY               	1D 1H NMR based differential metabolomics study of T3M4 cells, which are
PR:PROJECT_SUMMARY               	gemcitabine sensitive, and gemcitabine resistant T3M4 cells (GemR) were cultured
PR:PROJECT_SUMMARY               	with or without gemcitabine treatment. 1D 1H NMR spectra were collected from the
PR:PROJECT_SUMMARY               	samples and analyzed using MVAPACK software (http://bionmr.unl.edu/mvapack.php).
PR:PROJECT_SUMMARY               	Using multivariate analysis, unique responses to gemcitabine treatment were
PR:PROJECT_SUMMARY               	revealed, which may be useful in the clinical setting for monitoring a
PR:PROJECT_SUMMARY               	patient’s therapeutic response.
PR:INSTITUTE                     	University of Nebraska-Lincoln
PR:DEPARTMENT                    	Chemistry
PR:LABORATORY                    	Robert Powers and Pankaj Singh labs
PR:LAST_NAME                     	Gebregiworgis
PR:FIRST_NAME                    	Teklab
PR:ADDRESS                       	552 Hamilton Hall, 639 N. 12th Street, Lincoln, NE, 68588, USA
PR:EMAIL                         	teklab@huskers.unl.edu
PR:PHONE                         	(402) 472-3039
PR:FUNDING_SOURCE                	NCI, NIGMS, AACR
PR:CONTRIBUTORS                  	Teklab Gebregiworgis, Fatema Bhinderwala, Vinee Purohit, Nina V. Chaika, Pankaj
PR:CONTRIBUTORS                  	K. Singh, and Robert Powers
#STUDY
ST:STUDY_TITLE                   	NMR metabolomics study of Gemcitabine resistant cancer cells
ST:STUDY_TYPE                    	NMR metabolomics
ST:STUDY_SUMMARY                 	1D 1H NMR spectra were collected from the samples and analyzed using MVAPACK
ST:STUDY_SUMMARY                 	software (http://bionmr.unl.edu/mvapack.php). Multivariate analysis was
ST:STUDY_SUMMARY                 	conducted to study the metabolic phenotypes of the samples.
ST:INSTITUTE                     	University of Nebraska-Lincoln
ST:DEPARTMENT                    	Chemistry
ST:LABORATORY                    	Dr. Robert Powers and Pankaj Singh labs
ST:LAST_NAME                     	Gebregiworgis
ST:FIRST_NAME                    	Teklab
ST:ADDRESS                       	552 Hamilton Hall, 639 N. 12th Street, Lincoln, NE, 68588, USA
ST:EMAIL                         	teklab@huskers.unl.edu
ST:PHONE                         	(402) 472-3039
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:CELL_BIOSOURCE_OR_SUPPLIER    	Gift from Dr. Michael Hollingsworth
SU:CELL_STRAIN_DETAILS           	T3M4
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	T3M4_01	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_02	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_03	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_04	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_05	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_06	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_07	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_08	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_09	Treatment:No | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_10	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_11	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_12	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_13	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_14	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_15	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_16	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_17	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_18	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_19	Treatment:Yes | Sensitivity:Sensitive	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_20	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_21	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_22	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_23	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_24	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_25	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_26	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_27	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_28	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_29	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_30	Treatment:No | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_31	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_32	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_33	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_34	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_35	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_36	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_37	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_38	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_39	Treatment:Yes | Sensitivity:Resistant	
SUBJECT_SAMPLE_FACTORS           	-	T3M4_40	Treatment:Yes | Sensitivity:Resistant	
#COLLECTION
CO:COLLECTION_SUMMARY            	For each of the cell culture, 1 x 106 cells were cultured and harvested at
CO:COLLECTION_SUMMARY            	70-80% confluence in a 100 mm Petri dish. The media was then removed by
CO:COLLECTION_SUMMARY            	aspiration upon harvesting, and the cells were washed twice with PBS at pH 7.2.
CO:COLLECTION_SUMMARY            	The cells were then lysed by the addition of 1 mL of an 80% methanol:water
CO:COLLECTION_SUMMARY            	mixture at -80oC followed by incubation for 15 minutes in a -80oC freezer. The
CO:COLLECTION_SUMMARY            	lysed cells were then transferred to a 1 ml Eppendorf tube using a cell scraper.
CO:COLLECTION_SUMMARY            	The cell lysate was centrifuged at 16,200 g for 5 minutes and the supernatant
CO:COLLECTION_SUMMARY            	was collected and transferred to a clean Eppendorf tube. 250 µL of nanopure
CO:COLLECTION_SUMMARY            	water (Nanopure, Dubuque, IA) was added to the cell debris, the sample was mixed
CO:COLLECTION_SUMMARY            	by pipetting, and then centrifuged as before. The two supernatants were
CO:COLLECTION_SUMMARY            	combined, and the sample was dried by vacuum evaporation (SpeedVac® Plus,
CO:COLLECTION_SUMMARY            	Savant, Thermo Scientific, Waltham, MA) followed by freeze-drying (Labconco,
CO:COLLECTION_SUMMARY            	Kansas City, MO).
CO:SAMPLE_TYPE                   	Cultured cells
CO:STORAGE_CONDITIONS            	-80?
#TREATMENT
TR:TREATMENT_SUMMARY             	T3M4 wild type (WT) pancreatic cancer cells were cultured in DMEM with
TR:TREATMENT_SUMMARY             	increasing concentrations of gemcitabine over a period of about 6 months. The
TR:TREATMENT_SUMMARY             	resistance status of the cells at each gemcitabine dose was determined by
TR:TREATMENT_SUMMARY             	calculating an IC50 using the MTT cytotoxicity assays. At the end of the 6-month
TR:TREATMENT_SUMMARY             	treatment, the cell lines generated (GemR) were approximately 500-1000 fold
TR:TREATMENT_SUMMARY             	resistant to gemcitabine as compared to the parental (WT) cells.Wild type T3M4
TR:TREATMENT_SUMMARY             	cells (WT), which are gemcitabine sensitive, and gemcitabine resistant T3M4
TR:TREATMENT_SUMMARY             	(GemR) were cultured with or without the addition of gemcitabine for the NMR
TR:TREATMENT_SUMMARY             	metabolomics studies. A total of four cell culture groups were prepared that
TR:TREATMENT_SUMMARY             	consisted of: (1) untreated T3M4 (WT) cells, (2) WT cells treated with 10 nM
TR:TREATMENT_SUMMARY             	gemcitabine for a period of 12 hours (WT+), (3) untreated GemR cells, and (4)
TR:TREATMENT_SUMMARY             	GemR cells treated with 10 nm gemcitabine for 12 hours (GemR+).
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The dried metabolite extracts were reconstituted in 600 µL of 50 mM phosphate
SP:SAMPLEPREP_SUMMARY            	buffer in 99.8% D2O (Isotec, St. Louis, MO) at pH 7.2 (uncorrected). 50 µM of
SP:SAMPLEPREP_SUMMARY            	TMSP (3-(tetramethysilane) propionic acid-2,2,3,3-d4) were added for spectral
SP:SAMPLEPREP_SUMMARY            	referencing. The solution was mixed by gentle votexing and centrifuged at 13000
SP:SAMPLEPREP_SUMMARY            	rpm for 5 min, and then the supernatant were transferred to 5 mm NMR tube.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	-
CH:INSTRUMENT_NAME               	-
CH:COLUMN_NAME                   	-
#ANALYSIS
AN:ANALYSIS_TYPE                 	NMR
AN:LABORATORY_NAME               	Dr. Robert Powers
AN:OPERATOR_NAME                 	Teklab Gebregiworgis
#NMR
NM:INSTRUMENT_NAME               	Bruker AVANCE DRX
NM:INSTRUMENT_TYPE               	FT-NMR
NM:NMR_EXPERIMENT_TYPE           	1D-1H
NM:SPECTROMETER_FREQUENCY        	500 MHz
NM:TEMPERATURE                   	25
NM:NUMBER_OF_SCANS               	128
NM:DUMMY_SCANS                   	16
NM:SPECTRAL_WIDTH                	5483 HZ
NM:NUM_DATA_POINTS_ACQUIRED      	32000
NM:NMR_RESULTS_FILE              	ST001090_AN001775_Results.txt	UNITS:ppm
#END